PhaseII study of protracted irinotecan infusion and a low-dose cisplatinfor metastatic gastric cancer
研究実績
検索結果：
Warning: Undefined variable $current_issue in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 49
Warning: Undefined variable $current_issue in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 49
すべて の研究実績
Warning: Undefined variable $current_achievement_cat in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 114
Warning: Undefined variable $current_issue in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 128
Warning: Undefined variable $current_achievement_cat in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 143
Warning: Undefined variable $current_issue in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 149
Warning: Undefined variable $current_issue in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 162
Warning: Undefined variable $current_issue in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/page-achievement.php on line 162
Phase I/II study of combination chemotherapy with UFT/LV + CPT-11 in patients with advanced colorectal cancer (OGSG0303)
Phase I/II Study of weekly Taxol(TXL) plus CPT-11 for patients with advanced/recurrent gastic cancer (AGC/RGC)
Phase II study of a new regimen for S-1 therapy aiming at adverse reaction mitigation for metastatic gastric cancer: a study by the Osaka Gastrointestinal Chemotherapy Study Group OGSG-0103
Phase II study of paclitaxel and doxifluridine in patients with S-1 failure gastric cancer
進行・再発大腸癌に対するUFT/LV+CPT-11併用化学療法の第I相試験(OGSG0303)
遠隔転移を伴う食道癌に対するドセタキセル+シスプラチン+5-FU併用療法の第II相試（OGSG0403）
TS-1 治療抵抗性の進行・再発胃がんに対するpaclitaxel/ doxifluridine 併用療法の第Ⅱ相臨床試験（OGSG 0302）
TS-1 抵抗性進行・再発胃癌に対するPaclitaxel/Doxifluridine併用療法の第Ⅱ相試験（OGSG0302・中間解析）
TS-1 治療抵抗性の進行・再発胃癌に対するPaclitaxel/Doxifluridine 併用療法の第 II 相臨床試験（OGSG 0302）